None listed
Conditions
Interventions
Intervention1: AASG-133-7A: Product to be used for 4 weeks.
Intervention2: AAFS-133-5A: Product to be used for 8 weeks.
Control Intervention1: Not Applicable: Not Applicable
Sponsors
ITC Life Sciences Technology Centre
Eligibility
Inclusion criteria
Inclusion criteria: 1) Volunteer in the age group of 19 to 45 years 2) Volunteers with Mild to Moderate Acne lesions and Acne prone skin 3) Volunteer who exhibits good tolerance to the investigational product with no signs of sensitivity.
Exclusion criteria
Exclusion criteria: 1) Pregnant or lactating women. 2) Volunteer undergoing treatment for anti-acne or skin lightening. 3) Volunteer with pre-existing systemic disease requiring long-term medication / genetic and endocrinal disorders/ drug induced Acne (self-declaration).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Product A : Reduction in the number of lesions, Comedones/ lesion Size, Severity/ Redness/ Pain Product B: Reduction in the number of lesions, Comedones/ lesion Size, Severity/ Redness/ Post acne marks/ Pain / poresTimepoint: 4 weeks and 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Product B 1.Improvement in skin hydration, skin even tone , texture, appearance, epidermal turnover rate 2. Prevention of newer acne eruptions, post acne marksTimepoint: 8 weeks;Product A 1. Prevention of post acne marks 2. Improvement in skin even tone, texture, appearanceTimepoint: 4 weeks | — |
Countries
India
Contacts
Public ContactDr Simran Sethi
Cliantha Research
Outcome results
None listed